The CEO of the Danish firm Ambu is keenly aware of the firm's competitors and the growing single-use endoscopy market, especially, will be attacked from many sides in the following year.
Ambu is especially fighting US competitors such as Boston scientific and Verathon for market shares, but the Ambu CEO Juan Jose Gonzalez' eyes are set on Japanese Olympus, which he thinks about to enter the market.
Get full access for you and your coworkers.Start a free company trial today
Already a member? Log in.